Your Source for Venture Capital and Private Equity Financings

Helix Announces $50M Series C

2021-06-07
SAN MATEO, CA, Helix has closed on its Series C funding round led by existing investors Warburg Pincus, DFJ Growth, Kleiner Perkins, Mayo Clinic and Temasek.
Helix, a population genomics and COVID-19 testing company, has closed on its Series C funding round led by existing investors Warburg Pincus, DFJ Growth, Kleiner Perkins Caufield Byers, Mayo Clinic and Temasek.

Helix's end-to-end genomics platform enables organizations to advance genomic research and accelerate the integration of genomic data into clinical care through its unique 'Sequence Once, Query Often' model. With this model, an individual's DNA can be collected, sequenced and securely stored once
(c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.
>> Click here for in-depth research on 9,000 startups and 5,000 VC investors